SARAH DODSON: Open Payments
NPI 1598275406 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,773 in 112 payments from 23 companies in 2025. Trend: 2023 $1,618 · 2024 $1,478 · 2025 $1,773
Food & beverage: $1,773
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $412 |
| AstraZeneca Pharmaceuticals LP | 12 | $312 |
| PFIZER INC. | 16 | $164 |
| Lilly USA, LLC | 6 | $102 |
| Amgen Inc. | 5 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $60 |
| Novo Nordisk Inc | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| Axsome Therapeutics, Inc. | 3 | $52 |
Products named: VRAYLAR, QULIPTA, AIRSUPRA, BREZTRI, MOUNJARO, FARXIGA, CAPLYTA, NURTEC ODT.
Industry payments across MO — which companies pay providers there.
